Immatics

@immatics

Immatics is active in the discovery and development of T-cell redirecting immunotherapies for the treatment of cancer. Legal notice:

Tuebingen, Germany
Vrijeme pridruživanja: rujan 2009.

Tweetovi

Blokirali ste korisnika/cu @immatics

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @immatics

  1. prije 13 sati

    On we stand up for a cancer-free world! Ajla Hrle, Director Strategic Alliances at Immatics, tells us what her contribution is to reduce the global impact of cancer.

    Poništi
  2. prije 16 sati

    Your strong communication, organizational and negotiation skills are searching for a new domain? Then come & join the Immatics team as (Sr) Manager Business Development! More:

    Poništi
  3. prije 23 sata

    What is your personal commitment to act against cancer? Claudia Wagner, Director and TCR Discovery & Validation at Immatics, tells us her story.

    Poništi
  4. 4. velj

    Yes! Immatics is in to cross-pollinate between disciplines for the benefit of patients: Join Amir Alpert’s talk about “TCR-Based Cancer Immunotherapies to Novel pMHC Targets” (Feb 5, 5-7pm)!

    Poništi
  5. 4. velj

    Mamta Kalra is Director CMC at Immatics and joins the fight against cancer. Today at learn what encourages her to keep going every day.

    Poništi
  6. proslijedio/la je Tweet

    It's DYK: In 2018, over 18 MILLION people around 🌏🌍🌎 had , and 10 MILLION people died from the disease. Let's beat cancer! Let's beat cancer! Let's beat cancer! Let's beat cancer! Let's beat cancer!

    , , i još njih 6
    Prikaži ovu nit
    Poništi
  7. 4. velj

    A future without – the time to act is now! Right before learn more about the personal commitment of Oliver Schoor, Vice President Discovery at Immatics.

    Poništi
  8. 3. velj

    Tomorrow is ! Stay tuned to learn more about our personal engagement at Immatics to create a future without cancer.

    Poništi
  9. 31. sij

    Look who came by our Houston site yesterday and wanted to learn more about Immatics: ! It was humbling to us and our staff to share with him our dream and vision of delivering the power of T cells to cancer patients.

    Poništi
  10. 29. sij

    NGS, Bash, TPM? If you know what this stands for and you want to translate reads into clinical targets then join the Immatics’ Bioinformatics team in fighting cancer!

    Poništi
  11. 28. sij

    10 days vein-to-vein time for TCR T cell manufacturing? It’s possible! Come and learn about it tomorrow in Ali Mohamed’s talk at the Vein-To-Vein Congress EU (Jan 28-30) in London on Jan 29, 2.45pm!

    Poništi
  12. 27. sij

    The CAR-T & Vein-To-Vein congresses are about to kick off in London (Jan 28-30) – and Immatics is ready to join: Meet Ali Mohamed and fellow panelists on Jan 28 at 9.30am & 11.45am to get latest cell manufacturing input!

    Poništi
  13. 24. sij

    Ihr medizinisches Fachwissen ist gefragt: Vor allem für histologische Arbeiten und Gewebeakquise, um im Team von Immatics als Pathologe an neuen Krebsimmuntherapien zu forschen. Wir freuen uns auf Ihre Bewerbung!

    Poništi
  14. 24. sij

    Join to advance our target validation! As Scientist at Immatics we’re happy for you to bring in your expertise and creativity to enhance and expand our approaches, esp. by histology.

    Poništi
  15. 24. sij

    It’s you who excels in managing alliances and partnerships? Then apply & support the Immatics team to maintain and expand its strategic network!

    Poništi
  16. 23. sij

    Herz, Hand und Mastermind gesucht: Unterstütze uns als Teamassistenz am Immatics-Standort in München und sende Deine Bewerbung!

    Poništi
  17. 17. sij

    LAN, WLAN, VPN & WAN sind keine Fremdworte für Dich? Netzwerkst Du gerne und sorgst für digitale Sicherheit? Dann bist Du bei uns als IT Network Engineer genau richtig: !

    Poništi
  18. 16. sij

    Bist Du im Labor in Deinem Element? Dann freuen wir uns auf Deine Bewerbung als Technische Assistenz (Bereich Immunologie) bei Immatics: !

    Poništi
  19. 14. sij

    You are and want to know more about Immatics delivering the power of to patients? Then don’t miss CEO Harpreet Singh’s presentation tomorrow (9.30 am). Read more: .

    Poništi
  20. 10. sij

    Are you ready for J.P. Morgan next week? Immatics is looking forward to meeting you at the largest symposium (Jan 13- 16) of the industry in San Francisco, CA. See an overview of our activities: .

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·